Literature DB >> 16328363

X-linked lymphoproliferative disease associated with hypogammaglobulinemia and growth-hormone deficiency.

Abdullah Alangari1, Abdullah Abobaker, Hirokazu Kanegane, Toshio Miyawaki.   

Abstract

X-linked lymphoproliferative disease is a rare immunodeficiency disorder characterized by extreme vulnerability to Epstein-Barr virus, dysgammaglobulinemia, and very high incidence of lymphoma. Growth-hormone deficiency has been described in rare cases to be associated with certain immunodeficiencies, such as X-linked agammaglobulinemia. We report a first case with X-linked lymphoproliferative disease associated with hypogammaglobulinemia and growth-hormone deficiency, which was confirmed by SAP gene mutation. The patient's mutation is novel. He is also the first patient with X-linked lymphoproliferative disease to be reported from Saudi Arabia. The patient's Btk expression and BTK gene were normal. Patients with hypogammaglobulinemia and GH deficiency should be considered to have not only X-linked agammaglobulinemia, but also X-linked lymphoproliferative disease.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16328363     DOI: 10.1007/s00431-005-0023-x

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  12 in total

1.  Correlation of mutations of the SH2D1A gene and epstein-barr virus infection with clinical phenotype and outcome in X-linked lymphoproliferative disease.

Authors:  J Sumegi; D Huang; A Lanyi; J D Davis; T A Seemayer; A Maeda; G Klein; M Seri; H Wakiguchi; D T Purtilo; T G Gross
Journal:  Blood       Date:  2000-11-01       Impact factor: 22.113

2.  X-linked hypogammaglobulinemia and isolated growth hormone deficiency.

Authors:  T A Fleisher; R M White; S Broder; S P Nissley; R M Blaese; J J Mulvihill; G Olive; T A Waldmann
Journal:  N Engl J Med       Date:  1980-06-26       Impact factor: 91.245

Review 3.  Molecular and cellular pathogenesis of X-linked lymphoproliferative disease.

Authors:  Kim E Nichols; Cindy S Ma; Jennifer L Cannons; Pamela L Schwartzberg; Stuart G Tangye
Journal:  Immunol Rev       Date:  2005-02       Impact factor: 12.988

4.  X-linked agammaglobulinemia, growth hormone deficiency and delay of growth and puberty.

Authors:  F Buzi; L D Notarangelo; A Plebani; M Duse; O Parolini; M Monteleone; A G Ugazio
Journal:  Acta Paediatr       Date:  1994-01       Impact factor: 2.299

5.  Molecular analysis of X-linked agammaglobulinemia with growth hormone deficiency.

Authors:  M E Conley; A W Burks; H G Herrod; J M Puck
Journal:  J Pediatr       Date:  1991-09       Impact factor: 4.406

6.  Immunodeficiency with increased immunoglobulin M associated with growth hormone insufficiency.

Authors:  T Ohzeki; K Hanaki; H Motozumi; H Ohtahara; H Hayashibara; Y Harada; M Okamoto; K Shiraki; Y Tsuji; H Emura
Journal:  Acta Paediatr       Date:  1993 Jun-Jul       Impact factor: 2.299

7.  Activation-dependent T cell expression of the X-linked lymphoproliferative disease gene product SLAM-associated protein and its assessment for patient detection.

Authors:  Kentaro Shinozaki; Hirokazu Kanegane; Hiroyoshi Matsukura; Ryo Sumazaki; Masahiro Tsuchida; Mika Makita; Yasuo Kimoto; Rie Kanai; Kumi Tsumura; Tatsuro Kondoh; Hiroyuki Moriuchi; Toshio Miyawaki
Journal:  Int Immunol       Date:  2002-10       Impact factor: 4.823

8.  An exon-skipping mutation in the btk gene of a patient with X-linked agammaglobulinemia and isolated growth hormone deficiency.

Authors:  B Duriez; P Duquesnoy; F Dastot; P Bougnères; S Amselem; M Goossens
Journal:  FEBS Lett       Date:  1994-06-13       Impact factor: 4.124

9.  Molecular genetic analysis of X-linked hypogammaglobulinemia and isolated growth hormone deficiency.

Authors:  D M Stewart; L D Notarangelo; C C Kurman; L M Staudt; D L Nelson
Journal:  J Immunol       Date:  1995-09-01       Impact factor: 5.422

10.  Shwachman-Diamond syndrome associated with hypogammaglobulinemia and growth hormone deficiency.

Authors:  S J Kornfeld; J Kratz; F Diamond; N K Day; R A Good
Journal:  J Allergy Clin Immunol       Date:  1995-08       Impact factor: 10.793

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.